Neurocrine Biosciences Statistics

Total Valuation

LON:0K6R has a market cap or net worth of GBP 9.78 billion. The enterprise value is 9.45 billion.

Market Cap	9.78B
Enterprise Value	9.45B

Important Dates

The next estimated earnings date is Thursday, July 31, 2025.

Earnings Date	Jul 31, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	98.97M
Shares Outstanding	n/a
Shares Change (YoY)	+0.78%
Shares Change (QoQ)	-0.39%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	97.78M

Valuation Ratios

The trailing PE ratio is 41.34 and the forward PE ratio is 16.94.

PE Ratio	41.34
Forward PE	16.94
PS Ratio	5.24
PB Ratio	4.99
P/TBV Ratio	5.06
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.07, with an EV/FCF ratio of 24.81.

EV / Earnings	39.93
EV / Sales	5.29
EV / EBITDA	22.07
EV / EBIT	25.44
EV / FCF	24.81

Financial Position

The company has a current ratio of 3.13, with a Debt / Equity ratio of 0.19.

Current Ratio	3.13
Quick Ratio	2.79
Debt / Equity	0.19
Debt / EBITDA	0.85
Debt / FCF	1.00
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 12.43% and return on invested capital (ROIC) is 10.76%.

Return on Equity (ROE)	12.43%
Return on Assets (ROA)	8.75%
Return on Invested Capital (ROIC)	10.76%
Return on Capital Employed (ROCE)	15.84%
Revenue Per Employee	1.04M
Profits Per Employee	131,492
Employee Count	1,800
Asset Turnover	0.67
Inventory Turnover	18.08

Taxes

In the past 12 months, LON:0K6R has paid 124.15 million in taxes.

Income Tax	124.15M
Effective Tax Rate	34.41%

Stock Price Statistics

The stock price has decreased by -12.75% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-12.75%
50-Day Moving Average	123.31
200-Day Moving Average	122.02
Relative Strength Index (RSI)	74.34
Average Volume (20 Days)	155

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.78

Income Statement

In the last 12 months, LON:0K6R had revenue of GBP 1.87 billion and earned 236.69 million in profits. Earnings per share was 2.29.

Revenue	1.87B
Gross Profit	1.19B
Operating Income	388.08M
Pretax Income	360.83M
Net Income	236.69M
EBITDA	410.14M
EBIT	388.08M
Earnings Per Share (EPS)	2.29

Full Income Statement

Balance Sheet

The company has 730.26 million in cash and 381.65 million in debt, giving a net cash position of 348.61 million.

Cash & Cash Equivalents	730.26M
Total Debt	381.65M
Net Cash	348.61M
Net Cash Per Share	n/a
Equity (Book Value)	1.96B
Book Value Per Share	19.82
Working Capital	863.00M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 410.14 million and capital expenditures -29.18 million, giving a free cash flow of 380.96 million.

Operating Cash Flow	410.14M
Capital Expenditures	-29.18M
Free Cash Flow	380.96M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 63.91%, with operating and profit margins of 20.78% and 12.68%.

Gross Margin	63.91%
Operating Margin	20.78%
Pretax Margin	19.32%
Profit Margin	12.68%
EBITDA Margin	21.96%
EBIT Margin	20.78%
FCF Margin	20.40%

Dividends & Yields

LON:0K6R does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.78%
Shareholder Yield	n/a
Earnings Yield	2.42%
FCF Yield	3.89%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0K6R has an Altman Z-Score of 8.35 and a Piotroski F-Score of 5.

Altman Z-Score	8.35
Piotroski F-Score	5